[ad_1]
Pfizer Modena vaccine, 80-90% of advanced countries insured
Middle developed and underdeveloped countries pay attention to AstraZeneca vaccine
AstraZeneca vaccine has insufficient efficacy and safety verification
[앵커]
Following UK approval for rush use of the vaccine, major developed countries continue to prepare for the vaccine. However, as the major advanced countries are working to secure “massive quantities” through “pre-contracts for vaccines,” national inequality is already becoming a reality. Reporter Kang Seong-ok reports Following the approval of the emergency use of the Pfizer and Bioentech vaccines in the UK, Germany is preparing rapidly, with six vaccination centers established in Berlin. Following Pfizer, modena vaccines are also being approved in the United States, the European Union, Canada, Switzerland, the United Kingdom, Israel, and Singapore. The Pfizer and Bioentech vaccines cost about 20,000 won per vaccine, and the Modena vaccine costs more than 30,000 won, both of which require two vaccines. These products are vaccines made with messenger RNA, so they require a cold storage facility below -70 degrees Celsius or -20 degrees Celsius. These two vaccines, which are expensive to inoculate and transport, are said to have already been contracted with developed countries for 80-90% of their production. Not only the underdeveloped countries, but also the middle industrial countries, are not even trying to get these vaccines. For this reason, a vaccine being developed by AstraZeneca in the UK is drawing attention. This company’s vaccine is cheap, about 4,000 won per vaccination, and is made with a virus, so it is convenient to store and transport. AstraZeneca, which is being developed with the University of Oxford in the UK, has also committed to supplying large quantities to countries that are hard to survive without making a profit. However, there are weaknesses that have not been sufficiently verified in terms of safety and efficacy. At the G20 summit last month, President Moon Jae-in and other leaders of major countries called for an equitable supply of vaccines and treatments, but in reality, the logic of national power and money is ahead. This is YTN Kang Seong-ok.
